Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atropine sulfate ophthalmic solution for slowing myopia progression in children
CTR20220342Phase 3Completed
- Sponsor
- Zhaoke Ophthalmology
- Start
- Feb 2022
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of atropine in myopia, sponsored by Zhaoke Ophthalmology. Started Feb 2022; status: completed.
02
Drugs
atropine
03
Conditions
myopia
Beyond the preview
Go deeper on CTR20220342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20220342.